• Skip to primary navigation
  • Skip to main content
atelix

atelix

Consultants to the Biotech and Pharmaceutical sector

  • Our Services
    • Start-up and Follow-on Financings
    • Corporate Strategy
    • Commercialisation of late-stage assets
    • Design and execution of partnering strategies
    • Broad therapeutic and technology platform experience
  • About
  • Contact

Call Us: +44 7880 787 626

Our Services

Broad therapeutic and technology platform experience

– NCEs, peptides, mAbs and mRNA
– Discovery to Approval; medtech; diagnostics
– Oncology/IO, Inflammation, Cardio/Metabolic, Neuroscience, Infectious Diseases

Start-up and Follow-on Financings

– International network of contacts
– Non-dilutive partnering validation
– Hybrid model deployment

Corporate Strategy

– Selective M&A
– Trade sales and exits
– Divestment of non-core assets/IP

Commercialisation of late-stage assets

– Managing multiple party process and bids
– Information audits and due diligences
– Multiple territories/jurisdictions

Design and execution of partnering strategies

– Technology and product positioning
– Targeted companies’ insights
– Success metrics to agreed timeframes

© 2021 · Atelix Ltd | Consultants to the Biotech and Pharmaceutical sector